LYKALABS — Lyka Labs Balance Sheet
0.000.00%
- IN₹2.87bn
- IN₹3.12bn
- IN₹1.38bn
- 81
- 16
- 12
- 25
Annual balance sheet for Lyka Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 81.4 | 188 | 143 | 36.9 | 55.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 87.4 | 185 | 202 | 314 | 467 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 291 | 522 | 442 | 507 | 674 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 837 | 856 | 637 | 688 | 771 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,900 | 1,856 | 1,515 | 1,569 | 1,762 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 492 | 994 | 326 | 378 | 466 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,158 | 1,723 | 1,061 | 887 | 727 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -258 | 133 | 454 | 682 | 1,036 |
| Total Liabilities & Shareholders' Equity | 1,900 | 1,856 | 1,515 | 1,569 | 1,762 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |